1 – 17 of 17
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
A modified Drug Attitude Inventory used in long-term patients in sheltered housing.
(
- Contribution to journal › Article
- 2011
-
Mark
Development and validation of the Fast Assessment in Acute Treatment of Psychosis-Observation Rating Scale (FAST-O)
(
- Contribution to journal › Article
- 2009
-
Mark
Remission in schizophrenia: analysis in a naturalistic setting.
(
- Contribution to journal › Article
-
Mark
Ny psykiatrisk tvångslagstiftning: en lag eller två?
(
- Contribution to journal › Article
- 2007
-
Mark
A multisite study of community treatment programs for mentally ill offenders with major mental disorders - Design, measures, and the forensic sample
(
- Contribution to journal › Article
-
Mark
Nicotine use and its correlates in patients with psychosis
(
- Contribution to journal › Article
-
Mark
Five-year follow-up during antipsychotic treatment: efficacy, safety, functional and social outcome
(
- Contribution to journal › Article
-
Mark
Costs of schizophrenia during five years
2007) 11th International Congress on Schizophrenia Research In Schizophrenia Bulletin 33(2). p.485-485(
- Contribution to journal › Published meeting abstract
-
Mark
Costs of schizophrenia during five years
(
- Contribution to journal › Article
-
Mark
Clinical decision-making during 5 years of antipsychotic treatment
(
- Contribution to journal › Article
-
Mark
Prolactin level during 5 years of risperidone treatment in patients with psychotic disorders.
(
- Contribution to journal › Article
-
Mark
Weight development in patients treated with risperidone: a 5-year naturalistic study
(
- Contribution to journal › Article
- 2006
-
Mark
Psykiatri. En orienterande översikt.
2006)(
- Book/Report › Book
-
Mark
Tardive dyskinesia and antipsychotics: a 5-year longitudinal study of frequency, correlates and course.
(
- Contribution to journal › Article
- 2005
-
Mark
Current therapy issues and unmet clinical needs in the treatment of schizophrenia: a review of the new generation antipsychotics.
(
- Contribution to journal › Scientific review
- 2003
-
Mark
Premorbid IQ and schizophrenia Increasing cognitive reduction by episodes.
(
- Contribution to journal › Article
- 2001
-
Mark
Schizophrenia - progressive and massive decline in response readiness by episodes
(
- Contribution to journal › Article